Tribute Pharmaceuticals Canada Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2016-02-05: Federal exemption Rule 506(b); Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Each convertible note bears interest at 2.5% for up to 6 years with at the Conversion Price defined in the Second Amended and Restated Facility Agreement dated December 7, 2015.; Date of first sale 2016-02-05; Total offering amount $75,000,000.
- 2014-10-21: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; SecurityToBeAcquired; Each Series A warrant is exercisable for 1 common share at an exercise price of $0.50 and each Series B warrant is exercisable for 1 common share at an exercise price of $0.60, both for a period of 24 months, subject to acceleration.; Date of first sale Yet to occur; Total offering amount $6,579,082.
- 2013-03-18: Federal exemption Rule 506; Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2013-03-01; Total offering amount $4,270,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2016-02-05 | Rule 506(b) | Debt; OptionToAcquire; SecurityToBeAcquired; Each convertible note bears interest at 2.5% for up to 6 years with at the Conversion Price defined in the Second Amended and Restated Facility Agreement dated December 7, 2015. | 2016-02-05 | $75,000,000 | $75,000,000 | $0 | 3 |
| 2014-10-21 | Rule 506(b) | OptionToAcquire; SecurityToBeAcquired; Each Series A warrant is exercisable for 1 common share at an exercise price of $0.50 and each Series B warrant is exercisable for 1 common share at an exercise price of $0.60, both for a period of 24 months, subject to acceleration. | Yet to occur | $6,579,082 | $0 | $6,579,082 | 13 |
| 2013-03-18 | Rule 506 | Equity; OptionToAcquire; SecurityToBeAcquired | 2013-03-01 | $4,270,000 | $4,270,000 | $0 | 19 |